Jump to navigation

South Africa

Experts and activists demand more generous vaccine waivers

Over a year after India and South Africa called for emergency measures, WTO members have proposed a plan to waive patents on COVID-19 vaccines

Pressure is building on President Cyril Ramaphosa to reject a compromise proposal offered by the United States and the European Union for a temporary waiver of intellectual property (IP) on Covid-19 vaccines (AC Vol 63 No 7, Vaccine patent negotiators agree compromise formula).

Over 300 civic activists, trades unions, academics, and experts from across the world, including economics laureate Joseph Stiglitz wrote to India's Prime Minister Narendra Modi and Ramaphosa describing the leaked text on IP waivers 'inadequate' and 'a step backwards from an already untenable status quo.'

It is almost 18 months since India and South Africa asked the World Trade Organization to waive IP rights for medicines in the hope of aiding the 'prevention, containment and treatment of Covid-19'.

South African and Indian officials joined the talks that led to the compromise text prepared by the US and EU, but Ramaphosa and his ministers are yet to comment on its contents.

The leaked text proposes that the waiver would cover IP rights only on vaccines but not on treatments for Covid-19. It also states that, within six months of a final agreement, WTO members must decide on whether to extend it to include Covid-19 diagnostics and therapeutics as well. For the moment, there is no timetable for a full WTO meeting to approve or reject the plan. It would require consensus support.

It also suggested that the agreement would be restricted to five years. The waiver would apply to those WTO members that exported less than 10% of the world's vaccine doses in 2021; that provision would mean the EU, China, and the US could not benefit from the waiver.

The proposal, despite its modesty, is opposed by the pharmaceutical conglomerates. The European Federation of Pharmaceutical Industries and Associations (EFPIA) called 'on governments across Europe and around the world to urgently rethink discussions on a Covid vaccine waiver and instead focus on the real barriers to global vaccine equity'.



Related Articles

DISPATCHES

Vaccine patent negotiators agree compromise formula

World Trade Organization chief Okonjo-Iweala applauds progress but warns of struggle to convince all members states to back it

The lead team of negotiators has agreed a compromise on patents waiver over three to five years for Covid-19 vaccines which will require ratification by all WTO members....

READ FOR FREE

The state of Cyril Ramaphosa

The President's speech to parliament on 13 February will say more about his fragile coalition of reformers than about the country he governs

For the past three decades each State of the Nation speech has been billed as the most important ever. Most – with the honourable exception of Nelson Mandela's...


Mabuza stirs a hornets' nest

The Deputy President’s plans for another term highlight tensions in the ANC as factions jockey for position

The country's rarely seen Deputy President, David Mabuza, was sharply reprimanded by the governing African National Congress when he casually threw his hat into the ring for re-election...


Zuma, Buthelezi and the Zulu nation

The exit of Inkatha leader Mangosuthu Buthelezi from politics and the rise and rise of Jacob Zuma as a national leader with an unassailable base in KwaZulu-Natal is a moment of truth for South Africa’s Zulus.

The Inkatha Freedom Party, so long dominant in KwaZulu-Natal (KZN), is losing its grip and risks disintegration. Its leader, Chief Mangosuthu Buthelezi, told its national conference (13-14 October)...


ANC cabinet contenders step up lobbying

President Ramaphosa is using party committees to consolidate his grip ahead of national elections next year

South Africans, still buckling under the strain of crippling daily power cuts with no end in sight, are waiting for the appointment of a Minister of Electricity, announced...